Overview
Hiroaki Abe practices practicing medicine in Yahaba, Japan.
His clinical expertise encompasses Lysinuric Protein Intolerance, Liver Failure, Cirrhosis, and Liver Cancer.
He is actively involved in clinical research, co-authoring 16 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hiroaki Abe
Is Hiroaki Abe a top-rated expert for Lysinuric Protein Intolerance?
MediFind is an objective health platform that identifies experts based on real-world data. Hiroaki Abe is classified as an Experienced expert for Lysinuric Protein Intolerance, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hiroaki Abe participate in research or clinical trials?
Yes. Hiroaki Abe has published 16 articles and abstracts on conditions like Lysinuric Protein Intolerance. You can view a list of Hiroaki Abe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- CirrhosisMr. Abe isExperienced. Learn about Cirrhosis.
- Liver CancerMr. Abe isExperienced. Learn about Liver Cancer.
- Liver FailureMr. Abe isExperienced. Learn about Liver Failure.
- Lysinuric Protein IntoleranceMr. Abe isExperienced. Learn about Lysinuric Protein Intolerance.